Merilog 100 UNT/ML in 3 ML Pen Injector
- RxCUI
- 2705745
- RxNorm name
- Merilog 100 UNT/ML in 3 ML Pen Injector
- Display name
- Merilog 100 UNT/ML in 3 ML Pen Injector
- Full name
- Merilog 100 UNT/ML in 3 ML Pen Injector
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761325 | Merilog | insulin aspart-szjj | 351(k) Biosimilar | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MERILOG | INSULIN ASPART-SZJJ | Sanofi-Aventis U.S. LLC | eee07a52-1102-4d48-9782-26061db175ad | 2025-10-07 | Warnings, Adverse reactions | 2705745 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| eee07a52-1102-4d48-9782-26061db175ad | Merilog 100 UNT/ML in 3 ML Pen Injector | PSN | 8 | These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe | 20251007 |
| eee07a52-1102-4d48-9782-26061db175ad | Merilog 100 UNT/ML per 3 ML Pen Injector | SY | 8 | These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe | 20251007 |
| eee07a52-1102-4d48-9782-26061db175ad | 3 ML Merilog 100 UNT/ML Pen Injector | SY | 8 | These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe | 20251007 |
| eee07a52-1102-4d48-9782-26061db175ad | 3 ML insulin aspart-szjj 100 UNT/ML Pen Injector [Merilog] | SBD | 8 | These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe | 20251007 |
| eee07a52-1102-4d48-9782-26061db175ad | Merilog 100 UNT/ML per 3 ML SoloStar Pen | SY | 8 | These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe | 20251007 |